Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey

BACKGROUND: Homozygous familial hypercholesterolemia (HoFH) is a rare life-threatening condition that represents a therapeutic challenge. The vast majority of HoFH patients fail to achieve LDL-C targets when treated with the standard protocol, which associates maximally tolerated dose of lipid-lower...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Erasmo, Laura, Gallo, Antonio, Cefalù, Angelo Baldassare, Di Costanzo, Alessia, Saheb, Samir, Giammanco, Antonina, Averna, Maurizio, Buonaiuto, Alessio, Iannuzzo, Gabriella, Fortunato, Giuliana, Puja, Arturo, Montalcini, Tiziana, Pavanello, Chiara, Calabresi, Laura, Vigna, Giovanni Battista, Bucci, Marco, Bonomo, Katia, Nota, Fabio, Sampietro, Tiziana, Sbrana, Francesco, Suppressa, Patrizia, Sabbà, Carlo, Fimiani, Fabio, Cesaro, Arturo, Calabrò, Paolo, Palmisano, Silvia, D’Addato, Sergio, Pisciotta, Livia, Bertolini, Stefano, Bittar, Randa, Kalmykova, Olga, Béliard, Sophie, Carrié, Alain, Arca, Marcello, Bruckert, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427960/
https://www.ncbi.nlm.nih.gov/pubmed/34496902
http://dx.doi.org/10.1186/s13023-021-01999-8

Ejemplares similares

Ejemplares similares